239 related articles for article (PubMed ID: 34662441)
1. Glycoforms of human prostate-specific membrane antigen (PSMA) in human cells and prostate tissue.
Yuan W; Liu B; Sanda M; Wei R; Benicky J; Novakova Z; Barinka C; Goldman R
Prostate; 2022 Jan; 82(1):132-144. PubMed ID: 34662441
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific membrane antigen (PSMA) glycoforms in prostate cancer patients seminal plasma.
Mackay S; Oduor IO; Burch TC; Troyer DA; Semmes OJ; Nyalwidhe JO
Prostate; 2024 Apr; 84(5):479-490. PubMed ID: 38151791
[TBL] [Abstract][Full Text] [Related]
3. Apical transport and folding of prostate-specific membrane antigen occurs independent of glycan processing.
Castelletti D; Fracasso G; Alfalah M; Cingarlini S; Colombatti M; Naim HY
J Biol Chem; 2006 Feb; 281(6):3505-12. PubMed ID: 16221666
[TBL] [Abstract][Full Text] [Related]
4. N-glycosylation and microtubule integrity are involved in apical targeting of prostate-specific membrane antigen: implications for immunotherapy.
Christiansen JJ; Rajasekaran SA; Inge L; Cheng L; Anilkumar G; Bander NH; Rajasekaran AK
Mol Cancer Ther; 2005 May; 4(5):704-14. PubMed ID: 15897234
[TBL] [Abstract][Full Text] [Related]
5. Cloning and characterization of canine prostate-specific membrane antigen.
Schmidt S; Fracasso G; Colombatti M; Naim HY
Prostate; 2013 May; 73(6):642-50. PubMed ID: 23359458
[TBL] [Abstract][Full Text] [Related]
6.
von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of prostate-specific membrane antigen from canine prostate carcinoma cells.
Wu LY; Johnson JM; Simmons JK; Mendes DE; Geruntho JJ; Liu T; Dirksen WP; Rosol TJ; Davis WC; Berkman CE
Prostate; 2014 May; 74(5):451-7. PubMed ID: 24449207
[TBL] [Abstract][Full Text] [Related]
8. Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA).
Mhaka A; Gady AM; Rosen DM; Lo KM; Gillies SD; Denmeade SR
Cancer Biol Ther; 2004 Jun; 3(6):551-8. PubMed ID: 15044850
[TBL] [Abstract][Full Text] [Related]
9. Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancer.
Lapi SE; Wahnishe H; Pham D; Wu LY; Nedrow-Byers JR; Liu T; Vejdani K; VanBrocklin HF; Berkman CE; Jones EF
J Nucl Med; 2009 Dec; 50(12):2042-8. PubMed ID: 19910433
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer.
Bandari RP; Jiang Z; Reynolds TS; Bernskoetter NE; Szczodroski AF; Bassuner KJ; Kirkpatrick DL; Rold TL; Sieckman GL; Hoffman TJ; Connors JP; Smith CJ
Nucl Med Biol; 2014 Apr; 41(4):355-63. PubMed ID: 24508213
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer.
Hillier SM; Maresca KP; Femia FJ; Marquis JC; Foss CA; Nguyen N; Zimmerman CN; Barrett JA; Eckelman WC; Pomper MG; Joyal JL; Babich JW
Cancer Res; 2009 Sep; 69(17):6932-40. PubMed ID: 19706750
[TBL] [Abstract][Full Text] [Related]
12. Solving the convergence problem in the synthesis of triantennary N-glycan relevant to prostate-specific membrane antigen (PSMA).
Walczak MA; Danishefsky SJ
J Am Chem Soc; 2012 Oct; 134(39):16430-3. PubMed ID: 22954207
[TBL] [Abstract][Full Text] [Related]
13. Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acid.
Yao V; Berkman CE; Choi JK; O'Keefe DS; Bacich DJ
Prostate; 2010 Feb; 70(3):305-16. PubMed ID: 19830782
[TBL] [Abstract][Full Text] [Related]
14. Current application and future perspectives of prostate specific membrane antigen PET imaging in prostate cancer.
Ceci F; Castellucci P; Fanti S
Q J Nucl Med Mol Imaging; 2019 Mar; 63(1):7-18. PubMed ID: 29521482
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen.
Wang X; Ma D; Olson WC; Heston WD
Mol Cancer Ther; 2011 Sep; 10(9):1728-39. PubMed ID: 21750220
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific membrane antigen expression in normal and malignant human tissues.
Silver DA; Pellicer I; Fair WR; Heston WD; Cordon-Cardo C
Clin Cancer Res; 1997 Jan; 3(1):81-5. PubMed ID: 9815541
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific membrane antigen expression in melanoma metastases.
Snow H; Hazell S; Francis N; Mohammed K; O'Neill S; Davies E; Mansfield D; Messiou C; Hujairi N; Nicol D; Harrington K; Smith M
J Cutan Pathol; 2020 Dec; 47(12):1115-1122. PubMed ID: 32529651
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific membrane antigen PET/MRI validation of MR textural analysis for detection of transition zone prostate cancer.
Bates A; Miles K
Eur Radiol; 2017 Dec; 27(12):5290-5298. PubMed ID: 28608163
[TBL] [Abstract][Full Text] [Related]
19. PSMA expression is highly homogenous in primary prostate cancer.
Tsourlakis MC; Klein F; Kluth M; Quaas A; Graefen M; Haese A; Simon R; Sauter G; Schlomm T; Minner S
Appl Immunohistochem Mol Morphol; 2015 Jul; 23(6):449-55. PubMed ID: 26153794
[TBL] [Abstract][Full Text] [Related]
20. Different glycoforms of prostate-specific membrane antigen are intracellularly transported through their association with distinct detergent-resistant membranes.
Castelletti D; Alfalah M; Heine M; Hein Z; Schmitte R; Fracasso G; Colombatti M; Naim HY
Biochem J; 2008 Jan; 409(1):149-57. PubMed ID: 17935484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]